The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials

被引:9
|
作者
Powell, Rebecca [2 ]
Barengolts, Denis [1 ]
Mayr, Luzia [1 ]
Nyambi, Phillipe [1 ,3 ]
机构
[1] NYU, Sch Med, Dept Pathol, New York, NY 10012 USA
[2] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA
[3] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA
来源
VIRUSES-BASEL | 2010年 / 2卷 / 02期
基金
美国国家卫生研究院;
关键词
HIV-1; Diversity; Rural Cameroon; phylogenetics; CIRCULATING RECOMBINANT FORM; HETERODUPLEX MOBILITY ASSAY; EQUATORIAL RAIN-FORESTS; GENETIC DIVERSITY; SUBTYPE-A; SEQUENCE ALIGNMENT; BLOOD-DONORS; TYPE-1; STRAINS; IDENTIFICATION;
D O I
10.3390/v2020639
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
West-Central Africa is an epicenter of the HIV pandemic; endemic to Cameroon are HIV-1 viruses belonging to all (sub) subtypes and numerous Circulating Recombinant Forms (CRFs). The rural villages of Cameroon harbor many strains of HIV-1, though these areas are not as well monitored as the urban centers. In the present study, 82 specimens obtained in 2000 and 2001 from subjects living in the rural villages of the South and West Regions of Cameroon were subtyped in gag, pol, and env and compared to 90 specimens obtained in 2006-2008 in the same regions, in order to analyze HIV-1 evolution in these rural areas. It was found that in the South Region, the proportion of unique recombinant forms (URFs) remained constant (similar to 40%), while the amount of URFs containing fragments of a CRF increased by 25%. (Sub) subtypes A1, F2, H, and K, and CRF09_cpx, identified in 2000 and 2001, were replaced by CRFs 01_AE, 13_cpx, 14_BG, and 18_cpx in 2006-2008. In the West Region, (sub) subtypes A2, C, G, and H, and CRFs 01_AE and 09_cpx, identified in 2000-2001, were replaced by sub-subtype A1 and CRFs 25_cpx and 37_cpx in 2006-2008. The proportion of URFs in the West Region dropped significantly over the time period by 43%. In both Regions, the proportion of CRF02_AG increased at all loci. These findings demonstrate that the evolution of HIV-1 is distinct for each endemic region, and suggests that the proportion of URFs containing CRF fragments is increasing as the genetic identity of the virus continues to shift dramatically. This highlights the concern that subtype-specific vaccines may not be relevant in Cameroon, and that the distribution of viral diversity in these regions of Cameroon must be carefully monitored.
引用
收藏
页码:639 / 654
页数:16
相关论文
共 50 条
  • [1] Evolution of HIV-1 Diversity in regions of High Viral diversity and implications for Vaccine design
    Powell, R.
    Barengolts, D.
    Mayr, L.
    Nyambi, P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A13 - A13
  • [2] HIV-1 Superinfection and its Implications for Vaccine Design
    Chohan, Bhavna H.
    Piantadosi, Anne
    Overbaugh, Julie
    CURRENT HIV RESEARCH, 2010, 8 (08) : 596 - 601
  • [3] HIV-1 diversity in Cameroon: new insights on the evolution of the virus
    Simon, T. Aime Marcel
    Lycias, Z.
    Eitel, M.
    Carolyn, W.
    Wendy, B. A.
    Darren, M. P.
    RETROVIROLOGY, 2012, 9
  • [4] HIV-1 diversity in Cameroon: new insights on the evolution of the virus
    T Aime Marcel Simon
    Z Lycias
    M Eitel
    W Carolyn
    BA Wendy
    MP Darren
    Retrovirology, 9
  • [5] Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials
    Baeten, JM
    Richardson, BA
    Martin, HL
    Nyange, PM
    Lavreys, L
    Ngugi, EN
    Mandaliya, K
    Ndinya-Achola, JO
    Bwayo, JJ
    Kreiss, JK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 24 (05) : 458 - 464
  • [6] HIV-1 (co)Receptors: Implications for Vaccine and Therapy Design
    Pollakis, Georgios
    Paxton, William A.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3701 - 3715
  • [7] Structural Basis of HIV-1 Neutralization: Implications for Vaccine Design
    Wilson, Ian A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C91 - C91
  • [8] HIV-1 diversity and vaccine development
    Nabel, G
    Makgoba, W
    Esparza, J
    SCIENCE, 2002, 296 (5577) : 2335 - 2335
  • [9] Some statistical issues in the design of HIV-1 vaccine and treatment trials
    Gilbert, PB
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2000, 9 (03) : 207 - 229
  • [10] Implications of HIV diversity for the HIV-1 pandemic
    Hemelaar, Joris
    JOURNAL OF INFECTION, 2013, 66 (05) : 391 - 400